Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

LYFEGEN-Series-A-Fund

More Like This

PR Newswire associated0

Lyfegen and EVERSANA Collaborate to Revolutionize Drug Pricing and Access with AI-Driven Insights

ProductLife Group Acquires Stragen Services, Strengthening Pharmacovigilance and Clinical Safety Expertise Within the European Market

Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt

Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Liberis partners with Nexi to launch revenue-based financing into Germany

PR Newswire associated0

Synergi raises €2M to plug European homes and utilities into flexibility markets

Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing